Table 1. . Consumption of resources associated with the diagnosis of ALK+ NSCLC and unit costs.
| Specific tests to diagnose NSCLC | Patients with suspected diagnosis of ALK+ NSCLC | Unit cost (updated €, 2018) [16] | |
|---|---|---|---|
| Patients (%) | Tests (n) | ||
| Bronchoscopy | 90 10 |
1 2 |
€264.75 |
| Tumor biopsy | 80 | 1 | €342.08 |
| Spirometry | 100 | 1 | €40.38 |
| Bone scan | 10 | 1 | €129.80 |
| Fine needle aspiration | 20 | 1 | €190.17 |
| Chest x-ray | 100 | 1 | €22.23 |
| Cerebral MRI | 80 | 1 | €280.31 |
| Chest computed tomography | 100 | 1 | €131.15 |
| Abdomen/pelvis computed tomography | 100 | 1 | €356.00 |
| Brain computed tomography | 20 | 1 | €135.75 |
| Positron emission tomography | 80 | 1 | €720.26 |
| Transthoracic core needle biopsy | 25 | 1 | €282.47 |
| Analytics, biochemistry, coagulation | 100 | 1 | €22.48 |
| Arterial gasometry | 100 | 1 | €4.27 |
| Electrocardiogram | 100 | 1 | €17.65 |
| Echocardiogram | 20 | 1 | €76.51 |
| Stress test | 20 | 1 | €159.99 |
| Specific ALK+ screening tests | |||
| Immunohistochemistry | 100 | 1 | €48.16 |
| FISH | 20 | 1 | €481.75 |
| Next-generation sequencing | 5 | 1 | €1510.60 |